Cargando…

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles

BACKGROUND: To determine if extended chemotherapy improves survival outcomes in patients with platinum-sensitive relapsed epithelial ovarian cancer (EOC) who have residual disease after six cycles of second-line chemotherapy. METHODS: In this study, 135 EOC patients who experienced platinum-sensitiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Se Ik, Hwang, Woo Yeon, Lee, Maria, Kim, Hee Seung, Kim, Kidong, Chung, Hyun Hoon, No, Jae Hong, Kim, Jae-Weon, Kim, Yong Beom, Park, Noh Hyun, Song, Yong-Sang, Suh, Dong Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720565/ https://www.ncbi.nlm.nih.gov/pubmed/33287758 http://dx.doi.org/10.1186/s12885-020-07658-8

Ejemplares similares

Feasibility of extended cycles of neoadjuvant chemotherapy in patients with advanced ovarian cancer in terms of prognosis and surgical outcomes
por: Kim, Nam Kyeong, et al.
Publicado: (2023)

Are Three Additional Cycles of Chemotherapy Useful in Patients with Advanced-stage Epithelial Ovarian Cancer After a Complete Response to Six Cycles of Intravenous Adjuvant Paclitaxel and Carboplatin?†
por: Kim, Hee Seung, et al.
Publicado: (2008)

Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
por: Kim, Se Ik, et al.
Publicado: (2023)

Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer
por: Kim, Se Ik, et al.
Publicado: (2021)

Value of Second Pass in Loop Electrosurgical Excisional Procedure
por: Kim, Kidong, et al.
Publicado: (2009)

Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
por: Kim, Se Ik, et al.
Publicado: (2019)

Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer
por: Kim, Se Ik, et al.
Publicado: (2014)

Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia
por: Kim, Ju-Hyun, et al.
Publicado: (2022)

Major clinical research advances in gynecologic cancer in 2011
por: Suh, Dong Hoon, et al.
Publicado: (2012)

The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2020)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
por: Kim, Se Ik, et al.
Publicado: (2019)

Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
por: Kim, Se Ik, et al.
Publicado: (2020)

Maximum daily dose of G-CSF is critical for preventing recurrence of febrile neutropenia in patients with gynecologic cancer: A case–control study
por: Kim, Nam Kyeong, et al.
Publicado: (2022)

Efficacy of methotrexate therapy in patients with tubal pregnancy and a serum human chorionic gonadotropin level above 10,000 IU/L
por: Kim, Kidong, et al.
Publicado: (2014)

Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons’ Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2015)

Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

Major clinical research advances in gynecologic cancer in 2012
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
por: Hue, Hyejeong, et al.
Publicado: (2019)

Use of a ring retractor to facilitate specimen removal in laparoscopic surgery
por: Hong, Deok Ho, et al.
Publicado: (2020)

HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP
por: Suh, Dong Hoon, et al.
Publicado: (2023)

Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
por: Kim, Hee Seung, et al.
Publicado: (2016)

Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer
por: Kim, Yeorae, et al.
Publicado: (2023)

Role of limonin in anticancer effects of Evodia rutaecarpa on ovarian cancer cells
por: Bae, Jae Ryul, et al.
Publicado: (2020)

Major clinical research advances in gynecologic cancer in 2016: 10-year special edition
por: Suh, Dong Hoon, et al.
Publicado: (2017)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection
por: Yoo, Baraem, et al.
Publicado: (2017)

Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer
por: Kim, Kidong, et al.
Publicado: (2022)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
por: Kim, Se Ik, et al.
Publicado: (2022)

Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer
por: Kim, Gilhyang, et al.
Publicado: (2021)

Major clinical research advances in gynecologic cancer in 2014
por: Suh, Dong Hoon, et al.
Publicado: (2015)

Laterally Extended Endopelvic Resection Versus Chemo or Targeted Therapy Alone for Pelvic Sidewall Recurrence of Cervical Cancer
por: Park, Soo Jin, et al.
Publicado: (2021)

Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2023)

Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: a Phase III study
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

Mutually exclusive antiproliferative effect of cell line‐specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV‐3 vs RMUG‐S
por: Kim, Miseon, et al.
Publicado: (2020)

Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
por: Kim, Se Ik, et al.
Publicado: (2020)

Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy
por: Kim, Se Ik, et al.
Publicado: (2021)

Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
por: Kim, Kidong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_moa2li4pcoeufgnte47vet4fhj